Fig. 7From: Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular CarcinomaScatter plots showed the correlation between ZBTB9 expression and IC50 of drugs (*p < 0.05; **p < 0.01; ***p < 0.001)Back to article page